At QuanBio, our mission is to revolutionize cardiovascular disease detection with our innovative AI-powered rapid screening platform, QuanCardio. Designed to address the critical unmet needs in detection of cardiovascular disease. the QuanCardio AI powered platform enables in-time detection of vascular diseases and provides precision medicine to prevent severe outcomes, ultimately improving patient care.
• Instant Assessment: Our platform provides over 25 biomarkers, including arterial aging and pulse wave velocity, within just 3 minutes.
• AI-Powered Precision: Utilizing state-of-the-art machine learning algorithms, QuanCardio is built on extensive clinical validation and large datasets.
• Comprehensive Analysis: Delivers critical information regarding arterial aging, aiding clinicians in making informed treatment decisions.
• Non-Invasive Technology: Analyzes the elasticity of arteries using advanced photoplethysmographic sensors, ensuring patient comfort and safety.
• Proven Science: Clinically validated with high correlation to the gold standard Carotid Ultrasound and supported by a validated FDA pathway.
Our end-to-end cardiovascular screening platform empowers healthcare practitioners with detailed insights, ensuring precise and personalized patient care at the point of care.